Related Experiment Video
Updated: Jan 21, 2026

Characterization of Functionally Associated miRNAs in Glioblastoma and their Engineering into Artificial Clusters for Gene Therapy
Published on: October 4, 2019
Snail expression contributes to temozolomide resistance in glioblastoma
Huaxin Liang1, Guangyong Chen1, Jiayan Li2
1Department of Neurosurgery, China-Japan Union Hospital of Jilin University Changchun 130033, Jilin, China.
Abstract:
Glioblastoma (GBM) is one of most malignancy tumors worldwide. Temozolomide (TMZ) is an important chemotherapy drug in GBM therapy. However, acquired TMZ-resistance frequently happens in GBM therapy and leads to high percentage of GBM recurrence. In our study, we demonstrated that Snail is upregulated in recurrent GBM tumors, and promotes the GBM cells resistant to TMZ induced apoptosis. Enhanced expression of Snail compromises the apoptosis induced by TMZ, and increases the cell migration and invasion. Reversely, depletion of Snail by siRNA has the opposite effects. In addition, we confirmed that the expression of Snail is modulated by STAT3 activation, since phospho-STAT3 level is relatively higher in recurrent GBM tumors and TMZ resistant cells. Knockdown of STAT3 turns down the expression of Snail in protein and mRNA level, and thereby sensitized the resistant GBM cells to TMZ treatment. Interestingly, the activation of STAT3 in GBM resistant cells is modulated by IL-6 secretion. Suppression of IL-6 abandons the STAT3 activation, and reduces its binding with Snail promoter. Inhibition of IL-6 by its antibody enhanced the killing effects of TMZ both in vivo and in vitro. Overall, our results provided a rational to overcome the TMZ resistant in GBM treatment by targeting IL-6-STAT3-Snail pathway.
Insights
Glioblastoma (GBM) resistance to temozolomide (TMZ) chemotherapy is linked to Snail. Targeting the IL-6/STAT3/Snail pathway can overcome this resistance, improving GBM treatment outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Glioblastoma (GBM) is a highly malignant brain tumor.
- Temozolomide (TMZ) resistance is a major challenge in GBM therapy, leading to tumor recurrence.
- Understanding the mechanisms of TMZ resistance is crucial for developing effective treatments.
Purpose of the Study:
- To investigate the role of Snail in acquired temozolomide resistance in glioblastoma.
- To elucidate the regulatory pathway involving IL-6, STAT3, and Snail in TMZ-resistant GBM.
- To explore therapeutic strategies targeting the IL-6/STAT3/Snail pathway to overcome TMZ resistance.
Main Methods:
- Analysis of Snail expression in recurrent GBM tumors and TMZ-resistant cell lines.
- Use of small interfering RNA (siRNA) to deplete Snail and STAT3.
- Assessment of apoptosis, cell migration, and invasion assays.
- Evaluation of IL-6 secretion and STAT3 activation.
- In vivo and in vitro experiments using IL-6 antibody inhibition.
Main Results:
- Snail is upregulated in recurrent GBM and confers resistance to TMZ-induced apoptosis.
- Enhanced Snail expression increases GBM cell migration and invasion.
- STAT3 activation, modulated by IL-6 secretion, regulates Snail expression.
- STAT3 knockdown resensitizes resistant GBM cells to TMZ.
- Inhibition of IL-6 enhances TMZ efficacy both in vitro and in vivo.
Conclusions:
- The IL-6/STAT3/Snail pathway plays a critical role in mediating temozolomide resistance in glioblastoma.
- Targeting IL-6 can disrupt this pathway, overcoming TMZ resistance.
- This study provides a potential therapeutic strategy for improving GBM treatment outcomes.
More Related Videos
Related Concept Videos
Binet's Contribution to Measures of Intelligence
Wechsler's Contribution to Measures of Intelligence
Resistivity
Resistance
Resistance and Conductance
Various factors impact the resistance of a conductor. Spiraling in stranded conductors increases their...
Equivalent Resistance

